HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leukotriene C4 production by normal-density and low-density eosinophils of atopic individuals and other patients with eosinophilia.

Abstract
With the use of a percoll gradient separation procedure, eosinophils of individuals with asthma and with allergy could be separated into normal- and low-density cell fractions. The presence of low-density eosinophils possibly reflects an ongoing process of activation of these cells induced by the allergic reaction. Ca-ionophore-induced leukotriene (LT) C4 production, in the absence of added substrates, demonstrated a decreased potency for LT generation by low-density eosinophils compared with the LT generation of normal-density cells (57 +/- 33 ng and 103 +/- 44 ng per 10(6) cells, respectively). In contrast with the Ca-ionophore-induced LT formation, incubations with serum-treated zymosan in the presence of glutathione demonstrated higher productions of LTC4 with the low-density eosinophilic subpopulation compared with normal-density cells. This is compatible with a possibly higher expression of complement C3b receptors on the low-density eosinophils. Total arylsulfatase contents demonstrated that low-density eosinophils are not degranulated with respect to their small granules. Although release of the large granules by low-density eosinophils cannot be excluded, electron-microscopy studies indicated that degranulation is not the only (or major) factor that determines the density of the various eosinophilic subpopulations.
AuthorsH F Kauffman, B van der Belt, J G de Monchy, H Boelens, G H Koëter, K de Vries
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 79 Issue 4 Pg. 611-9 (Apr 1987) ISSN: 0091-6749 [Print] United States
PMID3558998 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • SRS-A
Topics
  • Cell Count
  • Eosinophilia (blood)
  • Eosinophils (cytology, metabolism)
  • Humans
  • Hypersensitivity, Immediate (blood)
  • SRS-A (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: